Fig. 2From: Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trialiDFS in Kaplan–Meier analysis for TIL+ (baseline lymphocyte-predominant status) versus TIL− in A all patients, B patients with non-pCR and C patients with pCRBack to article page